Insulin Pump Market to reach USD 13.37 Billion by 2032, and grow at a CAGR of 8.36%.
Insulin pumps play a critical role in diabetes management by delivering continuous subcutaneous insulin to patients, helping them maintain optimal blood glucose levels. The latest government data from the Centers for Disease Control and Prevention (CDC) indicates that over 37.3 million people in the U.S. have diabetes, with 1.9 million being Type 1 diabetic patients—those who are most likely to use insulin pumps. According to the National Institutes of Health (NIH), nearly 7 million people in the U.S. utilize insulin therapies, with insulin pump usage on the rise.